http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5590924-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 |
| filingDate | 2004-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a436b9bac24486364ac8bfe1505cd1d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14b323c100edfe782819329ff3b5c7e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a90ae821bcbf2004901b7dcdb6f746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17a0fccc9c12714a30f699672241ac5 |
| publicationDate | 2005-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-5590924-A2 |
| titleOfInvention | INDOLILALKYLAMINE DERIVATIVES AS 5-HYDROXITRIPTAMINE-6 LIGANDS |
| abstract | 1.- A compound of formula I wherein Q is SO2, CO, CONR9 or CSNR10; n is an integer 2 or 3; R1 and R2 are each independently H, halogen, CN, OCO2R12, CO2R13, CONR14R15, CNR16NR17R18, SOmR19 , NR20R21, OR22, COR23, or a C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, cycloheteroalkyl, aryl or heteroaryl optionally each substituted R3 and R4 are each independently H or a C1-C6 alkyl group optionally substituted; R5 and R6 are each independently H or a C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, cycloheteroalkyl, aryl or heteroaryl optionally each substituted, or R5 and R6 can be taken together with the Atom to which they are attached to form an optionally substituted 5- to 7- member ring, optionally containing an additional heteroatom selected from O, N or S; R7 is H, halogen or a C1-C6 alkyl, C1-C6 alkoxy, aryl group or optionally substituted heteroaryl; R8 is a system d the optionally substituted 8- to 13-membered bicyclic or tricyclic ring, which has an N atom on the bridge of the molecule, and optionally contains 1, 2 or 3 additional heteroatoms selected from N, O or S; m is 0 or an integer 1 or 2; R9 and R10 are each independently H or a C1-C6 alkyl, aryl or heteroaryl group each optionally substituted; R12, R13, R19 and R23 are each independently H or a C1-C6 alkyl, C2 alkenyl group C6, C2-C6 alkynyl, C3-C6 cycloalkyl, cycloheteroalkyl, aryl or heteroaryl each optionally substituted; R14, R15 and R22 are each independently H or an optionally substituted C1-C6 alkyl group; and R16, R17, R18, R20 and R21 are each independently H or an optionally substituted C1-C4 alkyl group; or R20 and R21 can be taken together with the atom to which they are attached to form a 5- to 7- membered ring that optionally contains another heteroatom selected from O, N or S; or the stereoisomers of these or the pharmaceutically acceptable salts thereof. |
| priorityDate | 2001-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288 |
Total number of triples: 38.